EAM Global Investors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-22,893
Closed -$2.52M 214
2022
Q4
$2.52M Sell
22,893
-50,863
-69% -$5.59M 0.65% 38
2022
Q3
$4.35M Buy
+73,756
New +$4.35M 1.16% 13
2022
Q2
Sell
-57,073
Closed -$2.16M 285
2022
Q1
$2.16M Hold
57,073
0.4% 114
2021
Q4
$2.26M Buy
+57,073
New +$2.26M 0.4% 134